Toujeo is a brand name for insulin glargine, which is a long-lasting insulin medication used to control blood sugar levels in people with diabetes. Toujeo is produced by Sanofi, a global pharmaceutical company.
Toujeo is administered by injection and is typically taken once a day at the same time each day. It works by regulating glucose metabolism in the body and maintaining a more consistent blood sugar level throughout the day.
Toujeo has been approved by the Food and Drug Administration (FDA) for the treatment of both type 1 and type 2 diabetes in adults. It has also been approved for use in children ages six years and older with type 1 diabetes.
Some potential side effects of Toujeo include hypoglycemia (low blood sugar), injection site reactions, allergic reactions, and others. It is important to speak with a healthcare provider before beginning treatment with Toujeo, as well as to closely monitor blood sugar levels and follow dosage instructions carefully.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page